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Abstract Proton-induced reactions on the 9Be target are considered as a neutron source, and
dependence of neutron yield on target thicknesses is investigated. The optimal thickness of
the 9Be target with the design and optimization characteristics of a beam shaping assembly
(BSA) for neutron flux from the thick target is studied with the GEANT4 program. To create
the realistic model of the experiment, there are inserted two physics lists for nuclear and
electromagnetic reactions. To get a high flux of neutrons had taken into account usage of
special materials as moderators on the base of (n, 2n) nuclear reactions, as well as, moderators
which will decrease the energy of neutrons to achieve the appropriate thermal/epithermal
neutron flux. The creation of the system, which must be made from reflectors and moderators,
is a necessity to explore the possibility of an appropriate neutron flux achievement for medical
purposes, especially for boron neutron capture therapy (BNCT). GEANT4 simulations of this
scientific paper describe the study of IBA’s C18/18 cyclotron-based neutron sources and its
possible usage for therapies.
1 Introduction
An ability of 10B nuclei to capture thermal neutrons was shown first time by H.J. Taylor,
where the capture process has resulted in the nuclear fission of the 11B nuclei into 4He (alpha
particles) and 7Li ions. Right after this discovery, G.L. Locher suggested that the neutron
capture process could be used to treat cancer. Later it was called boron neutron capture
therapy (BNCT) and became a promising method of treatment of malignant tumors. Briefly
summarized, it is a two-step procedure: first, the patient is injected with a tumor-localizing
drug containing the non-radioactive isotope 10B that has a high propensity or cross section
to capture slow neutrons. In the second step, the patient is radiated with thermal/epithermal
neutrons. After the loss of energy during passage through tissue, neutrons are absorbed by
the capture agent, which subsequently emits alpha particles. These charged particles can
selectively kill tumor cells in which a sufficient amount of 10B is concentrated.
Therapeutic interest in BNCT has focused mainly on high-grade gliomas (brain tumors)
[1–3], and more recently on patients with recurrent tumors of the head and neck region
[4–8] who have failed conventional therapy. BNCT primarily is a biochemically rather than a
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physically targeted type of radiation therapy, and, therefore, it should be possible to selectively
destroy tumor cell by cell, providing that sufficient amounts of 10B and thermal/epithermal
neutrons are delivered to the site of the tumor.
To date, almost all BNCT clinical irradiation have used fission reactor neutron sources,
because of the appropriate neutron flux achievement; however accelerator-based neutron
sources are under development and may eventually provide another option to fission reactors.
Accelerator-based neutron sources are being developed with the anticipation of being easier to
site in hospitals and license than a dedicated nuclear reactor. Also, they could be more compact
and less expensive than comparable reactor sources. Generally, they produce low-intensity
neutron fluxes compared to reactor sources and this has been a problem for implementation.
An increase in intensity by more than an order of magnitude would be necessary if accelerators
are to be competitive with the better reactor sources for clinical BNCT.
Newly installed Cyclone 18/18 in the area of the Armenian National Science Laboratory
after A. Alikhanian has a possibility to produce 18 MeV proton beams with up to 100 μA
current, which is approximately 6.24 × 1014 proton/s. The modified cyclotron from IBA has
a 4 m vacuum pipe for passing external protons to the experimental hall, and the beam spot
on target is 10 mm [9, 10]. The aluminum foil with 500 μm thickness is installed right on
the end of the pipe as vacuum keeping window. The presence of the aluminum foil decreases
the initial beam energy from 18 to 14.8 MeV.
The complicated processes connected with the selection of the effective target with optimal
thickness, and the creation of the beam shaping assembly (BSA) was studied by GEANT4
program, to understand the possibility of the appropriate neutron flux achievement and its
usage in BNCT. BSA is needed to optimize the initial neutron flux and during the research,
were taken into account the usage and selection of those materials, which has possibilities
to multiply neutrons, and as result increase the flux and at the same decrease the energy.
The continuation of the optimal flux achievement should be followed by installing filtering
materials for thermal and fast neutrons. In the end, the fast and thermal components of the
final flux should be much less than the epithermal component, but the total flux should be
in the order of ~ 109 n/s/cm2 [11, 12]. As recommended by the international atomic energy
agency (IAEA), the number of epithermal neutrons in the BNCT applicable neutron flux
should be ~ 100 times more than thermal neutrons, and ~ 20 times more than fast neutrons.
2 Creation of the GEANT4 model
GEANT4 is the successor of the GEANT series of software toolkit developed by CERN.
To build a specific application, the user-physicist chooses from among the options given
by the program and implements code in user action classes supplied by the toolkit. In con-
trast, object-oriented methods help manage complexity and limit dependencies by defin-
ing a uniform interface and common organizational principles for all physics models [13].
Besides other parameters, inside the GEANT4 model of the current feasibility study were
used G4HadronPhysicsQGSP_BERT_HP and G4EmStandardPhysics physics lists, respon-
sible for electromagnetic and hadronic processes.
To obtain as high as possible neutron yield, a thick 9Be target has been used. It is installed
at a 3 cm distance after the vacuum pipe and has a 5 mm radius. All the channels of nuclear
reactions, leading to the emission of neutrons, were considered in GEANT4 calculations. The
9Be(p, xn) multiparticle reactions with thresholds less than 14.8 MeV are listed in Table 1.
Figure 1 is a GEANT4 calculation result [14], performed to estimate the optimal and effective
thickness of the target. Figure 1a presents neutron energy spectra for different thicknesses
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Table 1 The 9Be (p,xn) reactions with less than 14.8 MeV thresholds
Reaction Q value (MeV) Reaction threshold (MeV)
p + 9Be→ 9B + n −1.8504 2.0572
p + 9Be→ 9B + n + γ −1.8855 2.057
p + 9Be→ 8Be + p + n −1.6645 1.8507
p + 9Be→ 8Be + p + n + γ −1.7011 1.8507
p + 9Be→ 5Li + α + n + γ −3.5377 3.9333
p + 9Be→2α + p + n −1.5727 1.74859
Fig. 1 a Energy spectra of neutrons for 2.5 mm (1), 1 mm (2) and 0.5 mm (3) thicknesses of 9Be target,
b Neutron yield dependence from the 9Be target thicknesses
of the target (2.5 mm, 1.5 mm, and 0.5 mm), and Fig. 1b is the dependence of neutron yield
from the different thicknesses. The maximal yield of neutrons was possible to achieve in the
case of 2.5 mm thickness of 9Be target, as proton beam fully absorbed by the target.
The 2.5 mm thickness is selected as an optimal thickness of the target, to produce as high
as possible yield of neutrons. In the case of the thicker target, emitted secondary neutrons
will be captured, which will reduce neutron yield. Nevertheless, neutrons from 9Be(p, xn)
reaction source cannot be directly used in BNCT, due to the wide range energy distribution,
which reaches up to 13 MeV. The final spectrum must show a peak of a quasi-monochromatic
neutron, as close as possible to the thermal/epithermal region to make possible neutron capture
processes by boron-10. Based on the number of registered neutrons in the energy range up
to a few keV, it could be realistic, the usage of the neutron flux for BNCT. The accelerator-
based neutron sources (ANS) should be comparable with reactor-based neutron sources, and
usually, there is a necessity to increase the final neutron flux to achieve BNCT applicable
yield. This was taken into account before the moderation part for the selection of materials.
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3 Discussion and results
The enrichment of the thermal and epithermal components of the beam and the corresponding
formation of the flow must be performed using a Beam Shaping Assembly (BSA). The main
goal of this work is the design of the BSA using the software package GEANT4, which will
be useful for medical purposes, particularly for BNCT.
First, the BSA should be a composition of carefully selected moderators to reduce the
neutron energy to the thermal/epithermal range. Second, for an effective treatment, it is
necessary to use reflectors, collimators and shielding materials to have a proper focusing of
the quasi-monochromatic neutron flux, which will also satisfy the IAEA’s criteria.
The therapeutic dose of 10B isotope is greater or equal than 20 μg per gram of tumor
tissue or 109 of 10B per cell. At the same time, thermal/epithermal neutron flux must be high
enough to be effectively captured by each 10B located inside of the cell, as the main goal of
BNCT is to kill the tumor cell by cell.
Thermalization of neutrons could be done by using layers of different types of materials
when each layer could be applied for neutrons in the exact energetic range. At the same time,
the number of neutrons should not be low or non-applicable for BNCT.
Natural molybdenum with optimal thickness 20 cm, installed as the first layer of BSA,
works as a multiplier. With (n, 2n) nuclear reactions, it is possible to decrease the energy of
neutrons and at the same time get a higher amount of thermal/epithermal flux. Due to earlier
studies [15], it may be admitted that molybdenum is an optimal material for multiplication
of neutron yield and at the same time for thermalization on the base (n, xn) nuclear reactions.
Right after the nat Mo, there are installed 45-cm-thick iron and 45-cm-thick paraffin boric
acid to decrease the energy of neutrons as much as possible. Iron is a suitable material to
decrease the energy of neutrons down to 1 MeV, and the other important moderator is a mix
of paraffin and boric acid to make the flux thermal/epithermal.
Moderators should be covered by the reflector to focus the beam. In this case, 20-cm-thick
Pb is used as a reflector, which is known as one of the useful materials and widely used as
an optimal one [16–19].
In this GEANT4 model, the whole BSA system was covered by thick concrete from sides.
It was considered that the BSA should be installed in the wall, which will separate the room
for patients from the rest of the experimental hall. The created BSA gives the possibility to
achieve neutron flux, which is suitable with the International Atomic Energy Agency (IAEA)
recommendations. Fig. 2 presents the energy distribution of neutrons when BSA consisted of
20-cm-thick Mo, 45-cm-thick Fe and 45-cm-thick paraffin boric acid. As a result of GEANT4
simulations, the registered neutron flux is around 0.968 × 109n/s/cm2 from 6.24 × 10 14
proton/s (when the current is 100 μA) and consisted of 69% epithermal neutrons, around
17% fast neutrons, and thermal neutrons amount is just 14%. Experimentally the results
should be proven at A. Alikhanian National Science Laboratory, where the Cyclone 18/18 is
installed. Compared with previous result [14], where the BSA consisted from 5-cm-thick Bi,
55-cm-thick Fe, 10-cm-thick Al, 5-cm-thick graphite and 10-cm-thick 7LiF as moderators
and 10-cm-thick Pb as reflector surrounding the moderation system, the total flux was 0.96
× 106 n/s/cm2 from 6.24 × 1014proton/s and only 12% of neutrons were in the energetic
range of up to 10 keV, while the rest were fast neutrons.
To apply neutron flux for medical purposes or for BNCT, there is a necessity to study
epithermal neutrons with energies up to 10 keV, which loses energy because of tissue pene-
tration and becomes thermalized [20]. Fig. 3a, b presents the aforementioned energetic range
neutrons, which was possible to achieve by using BSA consisted from 20-cm-thick Mo neu-
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Fig. 2 Energy distribution of
neutrons after the BSA
Fig. 3 Energy (a) and angular (b) distribution of up to 10 keV neutrons
Fig. 4 BSA schema consisted from 20-cm-thick Mo (1), 45 cm Fe (2) and 45 cm Paraffin Boric Acid (3) as
moderators, and 20-cm-thick Pb (4) as reflector
tron multiplier, 45 cm Fe and 45 cm paraffin boric acid as moderators, and 20-cm-thick Pb
as reflector/collimator (Fig. 4).
Because of the application for medical purposes, the total dose includes not only the
influence of neutrons, but also gamma rays. Fig. 5a presents energy distribution of gamma
rays, and almost 99.4% of gammas have energies up to 6 MeV. It is known that even 6 MeV
monochromatic gamma ray flux is useful for radiotherapy [21–23].
The statistical error for the registered gamma rays from 7 to 9 MeV increased from 22 to
100%. In this case, 0.6% of gamma rays, which are in the aforementioned energetic region,
can be even less. Nevertheless, the estimation of gamma rays influence and its contribution on
the total dose should be done in greater detail in the future, but as a result of simulations the
123
69 Page 6 of 8 Eur. Phys. J. Plus (2020) 135:69
Fig. 5 Energy (a) and angular (b) distribution of gamma rays
registered flux is 1.083 × 1010 gamma/s/cm2 from the highest possible proton current, which
is 100 μA or around 6.24 × 1014 proton/s. It is important to take into account the focusing
of gamma rays as well. Figure 5b is the angular distribution, which shows that gamma flux is
mainly focused on the central part of the surface of the register/detector. The aforementioned
fact and the appropriate figure also show that the reflector of a BSA focuses not only neutrons
but gamma rays too. In the case of BNCT, the impact of gamma rays and fast neutrons should
be suppressed. It is worth to be mentioned that the capturing process of neutrons by boron
nucleus usually followed by 0.478 MeV gamma rays, which should be detected, for example
by SPECT. Due to the existence of gamma rays emitted from the target, as well as, from
other components of the BSA, it will make technical difficulties and impede the detection of
gamma rays from the capturing process. It is known that Pb is one of the widely used gamma
ray filters [24–26], but its influence on epithermal neutrons and on the final quality of the
neutron beam should be estimated only after deeply detailed investigations.
4 Summary
The subject of this work has been the simulation study by GEANT4 program to create
a model of BSA, which will thermalize neutrons and make them applicable for BNCT.
The comparison of neutron fluxes obtained previously by different types of BSA, with the
latest one, consisted of 20-cm-thick molybdenum, 45-cm-thick iron and 45-cm-thick paraffin
boric acid layers as moderators and 20-cm-thick lead as reflector, makes possible to achieve
0.968 × 109n/s/cm2 flux of neutrons from 6.24 × 1014proton/s. The suitability with IAEA
recommendations is quite high. It is worth to be mentioned that the necessary amount of
neutrons was possible to obtain, besides that, around 70% of neutrons are epithermal, which
is also an important achievement. The shielding problems due to the backscattered neutrons,
as well as fast neutrons and gamma rays, influence together with total dose calculations,
which is a matter of later research, and will be done in the nearest future after deeply detailed
investigations.
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